U.S Class(es): 026, 039, 044
| Name | Novartis Pharma AG, Trademark Department |
|---|---|
| Address | Postfach CH-4002 Basel, SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Jun-07-2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM | |
| Jun-11-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
| Jun-12-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Jun-16-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Jun-19-2018 | ASSIGNED TO EXAMINER | DOCKD | |
| Jun-19-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Jul-04-2018 | NOTICE OF PUBLICATION | NPUBO | |
| Jul-05-2018 | WITHDRAWN FROM PUB - OG REVIEW QUERY | PBCRZ | |
| Aug-29-2018 | NOTICE OF PUBLICATION | NPUBO | |
| Sep-05-2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
| Sep-05-2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
| Sep-18-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Sep-21-2018 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Dec-04-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Jan-03-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| Jan-16-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
| Jan-16-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| Feb-01-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Jan-19-2024 | CHANGE OF OWNER RECEIVED FROM IB | CHLDM | |
| Jun-20-2025 | CANCELLED SECTION 71 | C71TO |